[GENiusVac, a novel antitumor vaccine strategy based on allogeneic plasmacytoid dendritic cells]. | Rev Med Interne;32(5): 329-32, 2011 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

[GENiusVac, a novel antitumor vaccine strategy based on allogeneic plasmacytoid dendritic cells]. / GENiusVac, une stratégie vaccinale antitumorale innovante basée sur des cellules dendritiques plasmocytoïdes allogéniques.

Aspord, C; Charles, J; Leccia, M-T; Laurin, D; Richard, M-J; Chaperot, L; Plumas, J.

Affiliation

Aspord C; Inserm U823, Établissement français du sang (EFS) Rhone-Alpes, R&D Laboratory, 38701 La Tronche, France. carolineaspord@yahoo.com

Rev Med Interne ; 32(5): 329-32, 2011 May.

Article in Fr | MEDLINE | ID: mdl-21429635

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / Cancer Vaccines / Neoplasms Limits: Animals / Humans Language: Fr Journal: Rev Med Interne Year: 2011 Document type: Article Affiliation country: Francia

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dendritic Cells / Cancer Vaccines / Neoplasms Limits: Animals / Humans Language: Fr Journal: Rev Med Interne Year: 2011 Document type: Article Affiliation country: Francia